destruction of abnormal cardiac tissue responsible for cardiac arrhythmogenesis
whilst avoiding collateral tissue injury forms the cornerstone of catheter
ablation therapy. As the acceptance and performance of catheter ablation
increases worldwide, limitations in current technology are becoming increasingly
apparent in the treatment of complex arrhythmias such as atrial fibrillation.
This review will discuss the role of new technologies aimed to improve lesion
formation with the ultimate goal of improving arrhythmia-free survival of
patients undergoing catheter ablation of atrial arrhythmias.
Credits: Saurabh Kumar; Chirag R. Barbhaiya; Samuel Balindger; Roy M. John; Laurence M. Epstein; Bruce A. Koplan; Usha B. Tedrow; William G. Stevenson; Gregory F. Michaud